Instant immunity through chemically programmable vaccination and covalent self-assembly
- 17 March 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (11), 4378-4383
- https://doi.org/10.1073/pnas.0900147106
Abstract
The ability to instantly create a state of immunity as achieved in the passive transfer of hyperimmune globulin has had a tremendous impact on public health. Unlike passive immunization, active immunization, which is the foundation of vaccinology, is an anticipatory strategy with inherent limitations. Here we show that elements of active and passive immunization can be combined to create an effective chemistry-driven approach to vaccinology. Reactive immunization was used to create a reservoir of covalent polyclonal antibodies in 3 mouse strains that were subsequently engrafted with syngeneic CT26 colon or B16F10 melanoma tumors. Upon administration of designed integrin αvβ3 and αvβ5 adapter ligands, the induced covalent polyclonal antibodies self-assembled with the adapter ligands and the animals mounted an instant, chemically programmed, polyclonal response against the implanted tumors. Significant therapeutic responses were observed without recourse to adjuvant therapy. The chemically programmed immune responses were driven by antibody-dependent cellular cytotoxicity and complement-directed cytotoxicity. We suggest that this type of chemistry-driven approach to vaccinology is underexplored and may provide routes to vaccines to protect against diseases that have proven intractable to biology-driven vaccine approaches.Keywords
This publication has 36 references indexed in Scilit:
- Antigen-specific human polyclonal antibodies from hyperimmunized cattleNature Biotechnology, 2009
- β-Lactam-based approach for the chemical programming of aldolase antibody 38C2Bioorganic & Medicinal Chemistry Letters, 2009
- Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivorsNature, 2008
- Immunochemical termination of self-toleranceProceedings of the National Academy of Sciences, 2008
- Alpha-v Integrins as Therapeutic Targets in OncologyCancer Investigation, 2007
- Bifunctional Ligands that Target Cells Displaying the αvβ3 IntegrinChemBioChem, 2006
- Breaking the one antibody–one target axiomProceedings of the National Academy of Sciences, 2006
- Design and synthesis of αGal-conjugated peptide T20 as novel antiviral agent for HIV-immunotargetingOrganic & Biomolecular Chemistry, 2004
- Expression and Localization of αv Integrins and Their Ligand Vitronectin in Normal Ovarian Epithelium and in Ovarian CarcinomaGynecologic Oncology, 1996
- Redirecting the immune response: ligand-mediated immunogenicityJournal of the American Chemical Society, 1991